These results suggest that PAF-induced hearing loss resulting from cochlear hair cell damage may be mediated by NO production via iNOS, and suggest that PAF antagonists and NOS inhibitors like L-NAME could have therapeutic value in preventing SNHL associated with chronic otitis media. This evidence concerns the gene NOS2 and sensorineural hearing loss disorder.